AXXZIA Inc.
AXXZIA Inc. (4936.T) Financial Performance & Income Statement Overview
Explore the financials of AXXZIA Inc. (4936.T), including yearly and quarterly data on income, cash flow, and balance sheets.
AXXZIA Inc. (4936.T) Income Statement & Financial Overview
Review AXXZIA Inc. 4936.T income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $3.21B | $3.08B | $3.08B | $3.68B |
| Cost of Revenue | $915.57M | $856.10M | $847.58M | $731.74M |
| Gross Profit | $2.29B | $2.22B | $2.23B | $2.95B |
| Gross Profit Ratio | $0.71 | $0.72 | $0.72 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $13.87M | $0.00 |
| SG&A Expenses | $2.23B | $2.17B | $0.00 | $0.00 |
| Operating Expenses | $2.23B | $2.17B | $2.27B | $2.61B |
| Total Costs & Expenses | $3.15B | $3.02B | $3.11B | $3.34B |
| Interest Income | $5.30M | $0.00 | $3.22M | $4.30M |
| Interest Expense | $6.65M | $0.00 | $3.69M | $1.72M |
| Depreciation & Amortization | $49.46M | $44.44M | -$19.61M | $76.12M |
| EBITDA | $126.57M | $102.05M | -$55.25M | $437.21M |
| EBITDA Ratio | $0.04 | $0.03 | -$0.02 | $0.12 |
| Operating Income | $59.72M | $57.61M | -$35.64M | $340.80M |
| Operating Income Ratio | $0.02 | $0.02 | -$0.01 | $0.09 |
| Other Income/Expenses (Net) | $10.74M | -$6.53M | -$23.30M | $74.40M |
| Income Before Tax | $70.46M | $51.08M | -$58.95M | $415.20M |
| Income Before Tax Ratio | $0.02 | $0.02 | -$0.02 | $0.11 |
| Income Tax Expense | $37.96M | $23.44M | -$39.35M | $104.31M |
| Net Income | $32.89M | $29.30M | -$17.03M | $313.03M |
| Net Income Ratio | $0.01 | $0.010 | -$0.006 | $0.09 |
| EPS | $1.40 | $1.21 | -$0.70 | $12.78 |
| Diluted EPS | $1.40 | $1.21 | -$0.70 | $12.77 |
| Weighted Avg Shares Outstanding | $23.48M | $24.22M | $24.42M | $24.52M |
| Weighted Avg Shares Outstanding (Diluted) | $23.48M | $24.22M | $24.42M | $24.49M |
Over the past four quarters, AXXZIA Inc. demonstrated steady revenue growth, increasing from $3.68B in Q3 2024 to $3.21B in Q2 2025. Operating income reached $59.72M in Q2 2025, maintaining a consistent 2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $126.57M, reflecting operational efficiency. Net income rose to $32.89M, with EPS at $1.40. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan